Cough, Cold and Allergy (Hay Fever) Remedies in Singapore

  • ID: 4432193
  • Report
  • Region: Singapore
  • 31 pages
  • Euromonitor International
1 of 4
According to a local study carried out by GlaxoSmithKline in 2016, almost 70% of the respondents reported experiencing allergic symptoms throughout the year. This can be attributed to the tropical climate in Singapore, alongside factors such as dust, air conditioning and haze. Coupled with a strong trend towards self-care amongst the local population, this continued to drive demand for cough, cold and allergy (hay fever) remedies in 2017.

The Cough, Cold and Allergy (Hay Fever) Remedies in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SINGAPORE

List of Contents and Tables:
  • Headlines
  • Prospects
  • Greater Marketing Efforts Expected To Improve Consumers' Product Knowledge
  • Weak Sales Performance for Paediatric Cough/cold Remedies
  • Competitive Landscape
  • Ricola Asia Pacific Continues To Lead the Category
  • Zyrtec's Switch Supports Growth
  • Category Data
  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
  • Table 3 Sales of Decongestants by Category: Value 2012-2017
  • Table 4 Sales of Decongestants by Category: % Value Growth 2012-2017
  • Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
  • Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
  • Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
  • Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
  • Executive Summary
  • Consumer Health Achieves Steady Value Growth in 2017
  • New Product Development To Meet Consumers' Changing Needs
  • Players Compete With Aggressive Marketing Efforts
  • Drugstores/parapharmacies Leads, While Non-store Retailing Continues To Thrive
  • Consumer Health To Post Modest Growth Over the Forecast Period
  • Market Indicators
  • Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 10 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 11 Sales of Consumer Health by Category: Value 2012-2017
  • Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Summary 1 OTC: Switches 2016-2017
  • Sources
  • Summary 2 Research Sources
  • Executive Summary
  • Consumer Health Achieves Steady Value Growth in 2017
  • New Product Development To Meet Consumers' Changing Needs
  • Players Compete With Aggressive Marketing Efforts
  • Drugstores/parapharmacies Leads, While Non-store Retailing Continues To Thrive
  • Consumer Health To Post Modest Growth Over the Forecast Period
  • Market Indicators
  • Table 20 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 21 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 22 Sales of Consumer Health by Category: Value 2012-2017
  • Table 23 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 24 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 25 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 26 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 27 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 28 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 29 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 30 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Summary 3 OTC: Switches 2016-2017
  • Sources
  • Summary 4 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll